BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3059076)

  • 1. B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation.
    Nerl C; Janssen O; Kabelitz D
    Leukemia; 1988 Dec; 2(12 Suppl):50S-56S. PubMed ID: 3059076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
    Karray S; Emilie D; Galanaud P
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
    Carlsson M; Tötterman TH; Rosén A; Nilsson K
    Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
    van Kooten C; Rensink I; Aarden L; van Oers R
    Leukemia; 1993 Apr; 7(4):618-24. PubMed ID: 8464239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
    Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
    J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro.
    Aguilar-Santelises M; Mellstedt H; Jondal M
    Leukemia; 1994 Jul; 8(7):1146-52. PubMed ID: 8035606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
    Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
    Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia.
    Tokumine Y; Waki K; Nishimori Y; Kuratsune H; Inoue R; Nakamura Y; Ueda E; Machii T; Kitani T
    Leukemia; 1989 Jul; 3(7):516-21. PubMed ID: 2786598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia.
    Berrebi A; Shtalrid M; Klepfish A; Bassous L; Kushnir M; Shulman L; Vorst E; Hahn T
    Leukemia; 1994 Dec; 8(12):2214-6. PubMed ID: 7808009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
    Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
    Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay.
    Tucci A; James H; Chicheportiche R; Bonnefoy JY; Dayer JM; Zubler RH
    J Immunol; 1992 May; 148(9):2778-84. PubMed ID: 1315359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
    Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
    Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
    Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
    Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory effects of IL-4 on human B-cell response to IL-2.
    Galanaud P; Karray S; Llorente L
    Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
    Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
    J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
    Lasky JL; Thorbecke GJ
    Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cell-replacing factor(s): a comparison of recombinant and purified human B cell growth and differentiation factors.
    Smith SH; Shields JG; Callard RE
    Eur J Immunol; 1989 Nov; 19(11):2045-9. PubMed ID: 2689186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.